V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005525 | 220002161 | null | null | Palliative (P) | null | 2017-03-31 | Cytarabine Low Dose | 02 | null | 220028391 | CYTARABINE |
| 220005526 | 220002161 | 1.64 | 70 | Curative (C) | 2015-11-05 | 2015-11-24 | AML17 TRIAL | N | N | 220028391 | AML17 TRIAL |
| 220005527 | 220002161 | null | 104 | null | 2013-11-24 | 2013-11-24 | CYTARABINE | N | N | 220028391 | CYTARABINE |
| 220005528 | 220002162 | 1.69 | null | Palliative (P) | null | 2015-04-01 | Cytarabine Low Dose | null | null | 220028398 | CYTARABINE |
| 220005529 | 220002162 | 1.52 | 87.2 | Not known (9) | 2016-04-06 | 2016-04-06 | AML17 TRIAL | 1 | N | 220028398 | AML17 TRIAL |
| 220005530 | 220002163 | 1.74 | 100.9 | Curative (C) | 2016-04-26 | 2016-04-26 | AML17 TRIAL | Y | N | 220028402 | AML17 TRIAL |
| 220005531 | 220002164 | null | 123.3 | Curative (C) | 2017-07-13 | 2017-07-14 | Cytarabine Low Dose | null | null | 220028404 | CYTARABINE |
| 220005532 | 220002164 | null | null | null | 2017-10-11 | 2017-10-12 | Cytarabine Low Dose | 02 | N | 220028404 | CYTARABINE |
| 220005533 | 220002164 | 1.7 | 87.1 | Palliative (P) | 2013-03-07 | 2013-03-07 | Cytarabine Low Dose | N | null | 220028404 | CYTARABINE |
| 220005537 | 220002166 | 1.72 | 77 | Curative (C) | 2013-09-30 | 2013-09-30 | AML17 TRIAL | 1 | N | 220028420 | AML17 TRIAL |
| 220005539 | 220015988 | 1.71 | 77.8 | Curative (C) | 2016-06-22 | 2016-07-11 | AML17 TRIAL | 1 | N | 220028429 | AML17 TRIAL |
| 220005540 | 220015988 | null | 78.9 | Disease modification (D) | 2014-04-12 | 2014-04-12 | CYTARABINE | 2 | N | 220028429 | CYTARABINE |
| 220005541 | 220015988 | 1.73 | 56 | Adjuvant (A) | 2017-06-14 | 2017-06-14 | Cytarabine Low Dose | 02 | N | 220028429 | CYTARABINE |
| 220005542 | 220002167 | null | 0 | Palliative (P) | 2015-11-22 | 2015-11-24 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028437 | CYTARABINE |
| 220005543 | 220002168 | null | 80 | Palliative (P) | 2017-06-02 | 2017-06-02 | Trial Unspecified | Y | N | 220028439 | TRIAL |
| 220005544 | 220002168 | 1.56 | 93 | Curative (C) | 2015-12-26 | 2016-01-27 | AML17 TRIAL | Y | N | 220028439 | AML17 TRIAL |
| 220005545 | 220002168 | 0 | null | Not known (9) | 2014-09-02 | 2014-09-05 | AML17 TRIAL | N | N | 220028439 | AML17 TRIAL |
| 220005546 | 220002169 | 0 | null | Palliative (P) | null | 2014-06-23 | Cytarabine Low Dose | N | N | 220028448 | CYTARABINE |
| 220005547 | 220002170 | 1.67 | 85.5 | Curative (C) | 2013-09-28 | 2013-10-01 | AML17 TRIAL | N | N | 220028449 | AML17 TRIAL |
| 220005548 | 220011184 | 1.89 | null | Curative (C) | 2014-10-13 | 2014-10-13 | LI-1 TRIAL | Y | N | 220028450 | TRIAL |
| 220005549 | 220011184 | 1.65 | 85.699 | Curative (C) | 2014-07-12 | 2014-08-17 | AML17 TRIAL | Y | N | 220028450 | AML17 TRIAL |
| 220005550 | 220011184 | null | 58.8 | Adjuvant (A) | 2014-03-31 | 2014-03-31 | Cytarabine Low Dose | N | N | 220028450 | CYTARABINE |
| 220005551 | 220002171 | 1.47 | 63 | Curative (C) | 2014-03-09 | 2014-03-11 | AML17 TRIAL | Y | N | 220028456 | AML17 TRIAL |
| 220005552 | 220002171 | null | 88.6 | Curative (C) | 2017-01-31 | 2017-01-31 | AML17 TRIAL | Y | N | 220028456 | AML17 TRIAL |
| 220005553 | 220002171 | 1.61 | 121 | Disease modification (D) | 2014-12-05 | 2014-12-11 | Trial Unspecified | null | N | 220028456 | TRIAL |
| 220005554 | 220002171 | 1.7 | 76.2 | Curative (C) | 2014-09-25 | 2014-09-26 | AML17 TRIAL | 01 | N | 220028456 | AML17 TRIAL |
| 220005555 | 220002171 | 1.64 | null | Adjuvant (A) | 2014-02-21 | 2014-02-25 | Cytarabine Low Dose | 2 | N | 220028456 | CYTARABINE |
| 220005556 | 220002171 | 1.72 | null | Curative (C) | 2014-08-20 | 2014-08-21 | AML17 TRIAL | 02 | N | 220028456 | AML17 TRIAL |
| 220005557 | 220002172 | 0 | 64 | Palliative (P) | 2013-12-11 | 2013-12-13 | Cytarabine Low Dose | N | N | 220028471 | CYTARABINE |
| 220005558 | 220002172 | 1.69 | 118 | Adjuvant (A) | 2015-09-17 | 2015-09-17 | AML17 TRIAL | Y | N | 220028471 | AML17 TRIAL |
| 220005559 | 220002173 | null | 119.5 | Curative (C) | 2015-10-17 | 2015-10-17 | Trial Unspecified | 01 | N | 220028473 | TRIAL |
| 220005560 | 220002174 | 1.79 | 57 | null | 2015-01-21 | 2015-01-22 | AML17 TRIAL | 2 | Y | 220028475 | AML17 TRIAL |
| 220005561 | 220002174 | 1.73 | null | null | 2013-12-26 | 2013-12-26 | Cytarabine Low Dose | null | N | 220028475 | CYTARABINE |
| 220005562 | 220015992 | null | 50.9 | Palliative (P) | 2015-07-12 | 2015-07-12 | Cytarabine Low Dose | N | N | 220028479 | CYTARABINE |
| 220005563 | 220015992 | 1.66 | 69.9 | Not known (9) | null | 2014-12-07 | AML17 TRIAL | null | null | 220028479 | AML17 TRIAL |
| 220005564 | 220002175 | 1.64 | 66.1 | Curative (C) | 2017-12-03 | 2017-12-03 | AML17 TRIAL | N | N | 220028484 | AML17 TRIAL |
| 220005565 | 220002176 | 1.31 | 65 | Not known (9) | 2015-05-10 | 2015-05-11 | AML17 TRIAL | N | N | 220028486 | AML17 TRIAL |
| 220005566 | 220002176 | 1.59 | 68 | Palliative (P) | 2013-04-24 | 2013-04-24 | Trial Unspecified | Y | N | 220028486 | TRIAL |
| 220005567 | 220002177 | 1.65 | 84.3 | Curative (C) | 2013-08-22 | 2013-08-23 | AML17 TRIAL | null | null | 220028489 | AML17 TRIAL |
| 220005568 | 220002177 | 1.66 | 68.5 | Curative (C) | 2013-05-11 | 2013-05-11 | Trial Unspecified | 01 | null | 220028489 | TRIAL |
| 220005569 | 220015993 | 1.82 | 87 | Not known (9) | 2016-10-13 | 2016-10-13 | Trial Unspecified | 1 | N | 220028491 | TRIAL |
| 220005570 | 220002178 | 1.63 | 72.7 | Palliative (P) | null | 2014-11-14 | Cytarabine Low Dose | 2 | N | 220028492 | CYTARABINE |
| 220005571 | 220002179 | 0 | 79.4 | Disease modification (D) | 2015-01-28 | 2015-02-09 | Trial Unspecified | Y | null | 220028495 | TRIAL |
| 220005572 | 220011190 | null | null | Palliative (P) | 2015-12-14 | 2015-12-17 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220028498 | CYTARABINE |
| 220005573 | 220002180 | 1.58 | null | Palliative (P) | 2014-06-26 | 2014-07-01 | Cytarabine Low Dose | N | N | 220028499 | CYTARABINE |
| 220005574 | 220002181 | null | null | Palliative (P) | 2014-12-12 | 2014-12-18 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028500 | CYTARABINE |
| 220005575 | 220002181 | 1.68 | 94.3 | null | 2017-09-16 | 2017-09-20 | Cytarabine Low Dose | 2 | N | 220028500 | CYTARABINE |
| 220005576 | 220002181 | 1.71 | 69.4 | Palliative (P) | 2016-02-29 | 2016-02-29 | Trial Unspecified | Y | N | 220028500 | TRIAL |
| 220005577 | 220002182 | 1.7 | null | Curative (C) | 2014-10-21 | 2014-10-22 | AML17 TRIAL | 1 | null | 220028504 | AML17 TRIAL |
| 220005578 | 220002182 | 1.62 | 75 | Palliative (P) | 2017-06-25 | 2017-06-25 | Cytarabine Low Dose | N | N | 220028504 | CYTARABINE |